PNC Financial Services Group
TNYA icon

PNC Financial Services Group’s Tenaya Therapeutics TNYA Stock Holding History

PNC Financial Services Group’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,106
Closed -$630 – 5078
2025
Q1 		$630 Buy
1,106
+1,041
+1,602% +$1.03K ﹤0.01% 4593
2024
Q4 		$93 Hold
65
– – ﹤0.01% 4712
2024
Q3 		$125 Hold
65
– – ﹤0.01% 4712
2024
Q2 		$202 Buy
+65
New +$268 ﹤0.01% 4666

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

PNC Financial Services Group's TNYA Position: Q2 2025 in Review

PNC Financial Services Group sold out of Tenaya Therapeutics (TNYA) in Q2 2025, closing a stake of 1,106 shares — an estimated $630 sold.

PNC Financial Services Group first reported a position in TNYA in Q2 2024 and held it in 4 quarters. The position peaked at $630 in Q1 2025. 89 funds tracked by Wall St. Rank hold TNYA as of Q2 2025.

  • PNC Financial Services Group reported no remaining Tenaya Therapeutics position as of Q2 2025 after selling out during the quarter.
  • PNC Financial Services Group sold 1,106 Tenaya Therapeutics shares in Q2 2025, an estimated $630.
  • PNC Financial Services Group first reported a position in Tenaya Therapeutics in Q2 2024 and held it in 4 quarters.
  • PNC Financial Services Group's Tenaya Therapeutics position peaked at $630 in Q1 2025.
  • 89 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2025.

Based on PNC Financial Services Group's 13F filing for Q2 2025, filed 8 Aug 2025.